Hematopoietic Stem Cell Transplant Associated Thrombotic Microangiopathy (HSCT-TMA)
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| narsoplimab | OMEROS CORP (OMER) |
Frequently asked questions
How many drugs are in development for Hematopoietic Stem Cell Transplant Associated Thrombotic Microangiopathy (HSCT-TMA)?
BioSniper tracks 1 drug in development for Hematopoietic Stem Cell Transplant Associated Thrombotic Microangiopathy (HSCT-TMA) across 1 company.
How many clinical trials target Hematopoietic Stem Cell Transplant Associated Thrombotic Microangiopathy (HSCT-TMA)?
There are 1 clinical trial targeting Hematopoietic Stem Cell Transplant Associated Thrombotic Microangiopathy (HSCT-TMA) tracked by BioSniper.
Deep-dive into Hematopoietic Stem Cell Transplant Associated Thrombotic Microangiopathy (HSCT-TMA)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis